Radiation therapy following surgery for localized breast cancer: Outcome prediction by classical prognostic factors and approximated genetic subtypes(343 views) Pacelli R, Conson M, Cella L, Liuzzi R, Troncone G, Iorio V, Solla R, Farella A, Scala S, Pagliarulo C, Salvatore M
J Rad Res Journal Of Radiation Research (ISSN: 1349-9157, 0449-3060, 1349-9157electronic), 2013 Mar 1; 54(2): 292-298.
Keywords: Bootstrapping, Breast Cancer, Contralateral Breast Cancer, Multivariable Model, Adjuvant Therapy, Adult, Aged, Article, Breast Tumor, Controlled Clinical Trial, Controlled Study, Disease Free Survival, Female, Genetic Predisposition, Human, Incidence, Mastectomy, Methodology, Middle Aged, Mortality, Multimodality Cancer Therapy, Outcome Assessment, Prognosis, Proportional Hazards Model, Randomized Controlled Trial, Reproducibility, Risk Factor, Sensitivity And Specificity, Statistics, Survival Rate, Treatment Outcome, Tumor Recurrence, Very Elderly, 80 And Over, Breast Neoplasms, Combined Modality Therapy, Disease-Free Survival, Genetic Predisposition To Disease, Neoplasm Recurrence, Local, Outcome Assessment (health Care), Radiotherapy, Reproducibility Of Results, Survival Analysis,
Affiliations: *** IBB - CNR ***
Department of Diagnostic Imaging and Radiation Oncology, Federico II University, School of Medicine, via S. Pansini 5, 80131 Naples, Italy
Institute of Biostructures and Bioimages, National Council of Research (CNR), via T. de Amicis 95, 80145 Naples, Italy
Department of Functional and Biomorphological Science, Federico II University, School of Medicine, via S. Pansini 5, 80131 Naples, Italy
Department of Oncological Immunology, National Cancer Institute, G. Pascale, via M. Semmola, 80131 Naples, Italy
References: Ferlay, J., Autier, P., Boniol, M., Estimates of the cancer incidence and mortality in Europe in 2006 (2007) Ann Oncol, 18, pp. 581-59
Yi, M., Meric-Bernstam, F., Middleton, L.P., Predictors of contralateral breast cancer in patients with unilateral breast cancer undergoing contralateral prophylactic mastectomy (2009) Cancer, 115, pp. 962-971
Vichapat, V., Garmo, H., Holmberg, L., Prognosis of metachronous contralateral breast cancer: Importance of stage, age and interval time between the two diagnoses (2011) Breast Cancer Res Treat, 130, pp. 609-618
Van Nes, J.G., Putter, H., Van Hezewijk, M., Tailored followup for early breast cancer patients: A prognostic index that predicts locoregional recurrence (2011) Eur J Surg Oncol, 36, pp. 617-624
Burstein, H., Harris, J., Morrow, M., Malignant tumors of the breast (2011) Cancer Principles and Practice of Oncology, pp. 1401-1446. , Devita V, Lawrence T, Rosenberg S (eds) 9th edn. Philadelphia: Lippincott Williams & Wilkins
Perou, C.M., Sorlie, T., Eisen, M.B., Molecular portraits of human breast tumours (2000) Nature, 406, pp. 747-752
Desmedt, C., Haibe-Kains, B., Wirapati, P., Biological processes associated with breast cancer clinical outcome depend on the molecular subtypes (2008) Clin Cancer Res, 14, pp. 5158-5165
Fan, C., Prat, A., Parker, J.S., Building prognostic models for breast cancer patients using clinical variables and hundreds of gene expression signatures (2011) BMC Med Genomics, 4, p. 3
Parker, J.S., Mullins, M., Cheang, M.C., Supervised risk predictor of breast cancer based on intrinsic subtypes (2009) J Clin Oncol, 27, pp. 1160-1167
Nguyen, P.L., Taghian, A.G., Katz, M.S., Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy (2008) J Clin Oncol, 26, pp. 2373-2378
Hattangadi-Gluth, J.A., Wo, J.Y., Nguyen, P.L., Basal subtype of invasive breast cancer is associated with a higher risk of true recurrence after conventional breast-conserving therapy (2012) Int J Radiat Oncol Biol Phys, 82, pp. 1185-1191
Murthy, V., Chamberlain, R.S., Recommendation to revise the AJCC/UICC breast cancer staging system for inclusion of proven prognostic factors: ER/PR receptor status and HER2 neu (2011) Clin Breast Cancer, 11, pp. 346-347
Hannemann, J., Kristel, P., Van Tinteren, H., Molecular subtypes of breast cancer and amplification of topoisomerase II alpha: Predictive role in dose intensive adjuvant chemotherapy (2006) Br J Cancer, 95, pp. 1334-1341
Lemeshow, S., Hosmer, Jr.D.W., Estimating odds ratios with categorically scaled covariates in multiple logistic regression analysis (1984) Am J Epidemiol, 119, pp. 147-151
El Naqa, I., Bradley, J., Blanco, A.I., Multivariable modeling of radiotherapy outcomes, including dose-volume and clinical factors (2006) Int J Radiat Oncol Biol Phys, 64, pp. 1275-1286
El Naqa, I., Suneja, G., Lindsay, P.E., Dose response explorer: An integrated open-source tool for exploring and modelling radiotherapy dose-volume outcome relationships (2006) Phys Med Biol, 51, pp. 5719-5735
Sanpaolo, P., Barbieri, V., Genovesi, D., Prognostic value of breast cancer subtypes on breast cancer specific survival, distant metastases and local relapse rates in conservatively managed early stage breast cancer: A retrospective clinical study (2011) Eur J Surg Oncol, 37, pp. 876-882
Efron, B., Jackknife, bootstrap, other resampling methods in regression-analysis -discussion (1986) Annals of Statistics, 14, pp. 1301-1304
Zaky, S.S., Lund, M., May, K.A., The negative effect of triple-negative breast cancer on outcome after breastconserving therapy (2011) Ann Surg Oncol, 18, pp. 2858-2865
Gonzalez-Angulo, A.M., Timms, K.M., Liu, S., Incidence and outcome of BRCA mutations in unselected patients with triple receptor-negative breast cancer (2011) Clin Cancer Res, 17, pp. 1082-1089
Metcalfe, K., Gershman, S., Lynch, H.T., Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers (2011) Br J Cancer, 104, pp. 1384-1392
Lu, W.L., Jansen, L., Post, W.J., Impact on survival of early detection of isolated breast recurrences after the primary treatment for breast cancer: A meta-analysis (2009) Breast Cancer Res Treat, 114, pp. 403-412
Van Nes, J. G., Putter, H., Van Hezewijk, M., Tailored followup for early breast cancer patients: A prognostic index that predicts locoregional recurrence (2011) Eur J Surg Oncol, 36, pp. 617-624
Perou, C. M., Sorlie, T., Eisen, M. B., Molecular portraits of human breast tumours (2000) Nature, 406, pp. 747-752
Parker, J. S., Mullins, M., Cheang, M. C., Supervised risk predictor of breast cancer based on intrinsic subtypes (2009) J Clin Oncol, 27, pp. 1160-1167
Nguyen, P. L., Taghian, A. G., Katz, M. S., Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy (2008) J Clin Oncol, 26, pp. 2373-2378
Zaky, S. S., Lund, M., May, K. A., The negative effect of triple-negative breast cancer on outcome after breastconserving therapy (2011) Ann Surg Oncol, 18, pp. 2858-2865
Lu, W. L., Jansen, L., Post, W. J., Impact on survival of early detection of isolated breast recurrences after the primary treatment for breast cancer: A meta-analysis (2009) Breast Cancer Res Treat, 114, pp. 403-412
Radiation therapy following surgery for localized breast cancer: Outcome prediction by classical prognostic factors and approximated genetic subtypes
Cusanno F, Cisbani E, Colilli S, Fratoni R, Garibaldi F, Giuliani F, Gricia M, Lucentini M, Magliozzi ML, Santarivenere F, Torrioli S, Cinti MN, Pani R, Pellegrini R, Simonetti G, Schillaci O, Del Vecchio S, Salvatore M, Majewski S, De Vincentis G, Scopinaro F * Results of clinical trials with SPEM(278 views) Nucl Instrum Methods Phys Res Sect A, 2007 Feb 1; 497(1): 46-50. Impact Factor:3.221 ViewExport to BibTeXExport to EndNote